

U.S. pays higher drug prices, gets priority access *




(Alliance News) - AstraZeneca PLC on Tuesday announced that China's National Medical Products Association has approved benralizumab to treat patients ...


(Alliance News) - Stocks in London are called to open lower on Tuesday, as investors look ahead to a key inflation reading from the eurozone.


(Alliance News) - Daiichi Sankyo Co Ltd on Monday announced positive updates for Enhertu, with the cancer drug receiving support from US and European ...


(Sharecast News) - London's stock markets closed lower on Friday, weighed down by a stronger pound and mixed investor sentiment following the release ...


(Alliance News) - AstraZeneca PLC on Friday said Imfinzi has been approved in the US for the treatment of resectable non-small cell lung cancer before...


(Sharecast News) - AstraZeneca announced on Friday that the US Food and Drug Administration (FDA) has approved its drug durvalumab, branded Imfinzi, f...